morphology which can be determine by platelet distribution width (PDW) and also larger in size, this changes can be measured by both PDW and mean platelet volume (MPV). 7 Platelet indices such as PDW and MPV may be useful to show the association between platelet size and ischemic events. 8 The activated platelet is thought to be the major biological risk factor for pathogenesis of ACS. Inhibition of this process could play an important role in prevention of cardiovascular disease. 9 PDW is a quantitative measure of platelet size variation. An increased PDW indicate more variation of size (anisocytosis) which result from formation of pseudopodia and may be the predictor of platelet activation and turnover. PDW is more sensitive and specific than MPV in terms of platelet reactivity. 10 PDW is less explored in Bangladesh; no effective study was done to see the role of PDW in detection of ACS in Bangladesh.
Material and methods:
This cross sectional study conducted in Department of Clinical Pathology, in collaboration with Department of Cardiology, BSMMU and BIRDEM from September 2011 to August 2012. A total 142 adults (18 years above) Patients with clinically suspected acute coronary syndrome who were attended in cardiac emergency and admitted in coronary care unit (CCU) in the department of Cardiology, BSMMU, and BIRDEM, Dhaka were enrolled in this study. Among 79 patients were included in this study as cases (group I). They have ECG changes (ST-elevation, ST-depression, Tinversion, appearance of Q-wave), with or without troponin I positive and rest of 63 patients comprises as controls (group II) those have normal ECG findings, and cardiac marker troponin I was negative. Clinical history, medical reports, findings and information were documented in a pre designed data sheet with inform and written consent with help of ECG report. Some patients are dropped out from this study.
Known case of patients with congenital heart disease, hepatic and renal impairment, documented malignancy, with anti-platelet, anti-coagulants, anti-inflammatory therapy, lipid lowering agents and traumatic chest pain were excluded from this study.
CBC with PBF including platelet, ESR, platelet parameters (MPV & PDW), troponin I, serum creatinine, fasting blood glucose, lipid profile, SGPT were done for case selection. About 5.0 ml blood was collected from each patient after admission (before antiplatelet therapy) through an aseptic venipuncture from antecubital vein. From these 2.0 ml of that blood was collected in EDTA tube for complete blood count (CBC) and peripheral blood film (PBF). 3.0 ml blood was transferred into a clean, dry test tube and was centrifuged within an hour of collection to separate the clear serum. Complete blood count (CBC) and platelet parameters were estimated by automated Haematology autoanalyzer (SYSMEX-XT 4000i) within 2 hours which again rechecked manually by peripheral blood film.
Prior to the commencement of this study, the research protocol was approved by the Institutional Review Board (IRB) of BSMMU, Dhaka. Data were processed and analyzed by using computer software SPSS (Statistical package for social sciences version 17) by applying appropriate formula. The test statistics used to analyze the data was mean standard deviation (SD), t-test, and Chi-square test with 95% confidence interval. Test of validity done by receiver operative characteristic analysis curves.
Results:
A total of 142 patients were included in this study. Maximum 33(41.8%) and 25 (39.7%) patients age belonged to 51-60 years age group and mean age was found 55.05±10.73 and 54.5 10.39 years in group I and in group II (Table -I ) . The mean age difference was not Based on the receiver-operator characteristic (ROC) curves PDW had the best area under curve compared to platelet counts and MPV evaluated by troponin I. Receiver-operator characteristic (ROC) were constructed using PDW value of the patients between two groups, which gave a PDW cut off value of >12.7 fl as the value with a best combination of sensitivity and specificity for acute coronary syndrome. At this PDW cut-off value of >12.7 fl, the sensitivity and specificity of PDW in diagnosing acute coronary syndrome was found 94.3% and 52.8%, respectively (Fig 2) . Platelet count cut-off value of >225X10 9 /L showed sensitivity 83.0% and specificity 28.1% in the diagnosis of acute coronary syndrome. MPV cut-off value of >10.7 fl showed sensitivity 90.6% and specificity 49.4% in the diagnosis of acute coronary syndrome. 
Discussion:
Acute coronary syndromes (ACS) are a set of signs and symptoms due to rupture of a plaque and are a consequence of platelet rich coronary thrombus formation. 11 Though the improvement of treatment and primary prevention, ACS is still the chief cause of death in most developed and developing countries. 12, 13 The present cardiac markers are not sufficiently sensitive at an early stage of ACS. That's why an early and reliable marker is needed for accurate diagnosis of ACS. Platelet parameters especially PDW could be an important and reliable markers in early detection of ACS when other markers are not available. Because platelet activation is the preliminary steps of ACS; and PDW indirectly indicate the status of platelet. 11, 12 In our study, we found that ACS was associated with increase PDW. The study reveals that the mean (±SD) value of PDW was significantly higher in patients with ACS than controls. Similarly MPV also increases but platelet counts were lower in ACS that means inverse proportion to platelet count and PDW and MPV. Smith NM 14 observed increase PDW and MPV are index of platelet size and correlates with platelet activation, and also a reliable index of platelet activation, may be a potentially useful marker in cardiovascular risk stratification described a study done by Martin JF. 15 Nandwani S et al 16 and Khandekar MM et al 3 described in their studies all platelet volume indices including MPV, PDW and platelet large cell ratio (P-LCR) were increased significantly in patients with ACS than controls. Varol E et al, 17 Cemin R et al 18 and Yilmaz et al 19 also found that MPV was significantly higher in patients with ACS groups than controls, along with reverse changes in platelet count.
Similar findings found study done by, Mercan R et al 7 and Ranjith MP et al. 20 They found platelet counts were significantly lower in the ACS groups as compared to control subjects, but MPV was significantly higher in ACS.
There are many studies done where platelet volume had association with ACS. Chu SG et al 21 described MPV as a risk factor and prognostic indicator in cardiovascular disease. Lippi G et al 2 found in their study MPV was significantly associated with ACS than with non-ACS.
Previously there was no study on validity tests of platelet counts and PDW as known to us. There were only two studies found on values of platelet count and PDW and few studies on MPV. Here with findings of platelet count and PDW sensitivity and specificity in our study will enrich diagnostic modalities in patients with ACS. The sensitivity, specificity, positive and negative predictive values were determined through ROC curves against troponin I. In our study among the 79 cases, 53 were troponin I positive and 26 were troponin I negative. All of the control subjects were troponin I negative. According to diagnostic criteria 67 cases were diagnosed as AMI and 12 cases were UA where troponin I was negative. Among 67 AMI cases, only 53 cases were troponin I positive and 14 cases were initially troponin I negative and became positive later.
In case of PDW and MPV, we found significant differences between the groups. There are two hypotheses that described the increased these parameters. First, when platelet activated they change their size and shape (metamorphosis). Second, after platelet activation aggregation of more platelet this leads to release of younger platelet from bone marrow. These suggest that MPV and PDW are indirect indicators of platelet activation and their association with ACS. Among the platelet parameters PDW was most significant than MPV. These findings lead to the hypothesis that larger platelets as determined by their volumes, MPV and PDW may be useful markers in patients with ACS. Our data indicate that, higher PDW may become useful marker for early detection of ACS along with other biomarkers.
Conclusion:
The metamorphic platelets are haemostatically more active and trends to developing coronary thrombus formation leading to ACS. Patients with increased PDW could be identified easily and play an important role in early diagnosis of ACS and early initiation of anti-platelet therapy. There by prevention and development of fullblown of ACS. It could be used as a screening test of ACS from other non cardiac chest pain, and severity and prognosis of ACS. Limitation and recommendation of the study: The study was done in limited time of span and no comparison with angiographic findings. Further studies are required to assess whether PDW provide beneficial role to identify patients at early stages of ACS, clinical risk and whether therapeutic modification of this marker may lead to improved cardiovascular risk.
